Skip to main content
AMRX
NASDAQ Life Sciences

Amneal Wins FDA Nod for Expanded Iohexol Line, Tapping $706M Market

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$18.03
Mkt Cap
$5.761B
52W Low
$7.665
52W High
$18.08
52W Position info
135% above low
Off High info
at 52W high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

AMRX has more than doubled off its 52-week low of $7.665.

Summary

Amneal received FDA approval for additional strengths and vial sizes of its generic iohexol contrast agent, covering 350 mg/mL in 50, 75, and 100 mL vials and 300 mg/mL in 50 mL. The company plans to launch in Q3 2026, targeting a U.S. market worth $706 million annually per IQVIA. This builds on its existing 300 mg/mL 100 mL approval and positions Amneal to capture the majority of iohexol demand. The news adds a new product catalyst to the Kashiv BioSciences acquisition narrative from April, reinforcing the injectables growth story.

At the time of this announcement, AMRX was trading at $18.03 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.8B. The 52-week trading range was $7.67 to $18.08. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

AMRX - Latest Insights

AMRX
Nov 09, 2026, 4:21 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $21.28
Real-time Price: $21.74 info
Change: +$0.460 (+2%) info
Market Cap: $7.574B info
AMRX
Nov 03, 2026, 6:00 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $20.23
Real-time Price: $21.74 info
Change: +$1.51 (+7%) info
Market Cap: $7.574B info
AMRX
Nov 03, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $20.20
Real-time Price: $21.74 info
Change: +$1.54 (+8%) info
Market Cap: $7.574B info
AMRX
Oct 23, 2026, 4:05 PM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $20.38
Real-time Price: $21.74 info
Change: +$1.36 (+7%) info
Market Cap: $7.574B info
AMRX
Sep 18, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $18.71
Real-time Price: $21.74 info
Change: +$3.03 (+16%) info
Market Cap: $7.574B info